BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2981040)

  • 1. Complications of Metrizamide (amipaque) myelography.
    Stewart JR; Thorne RP
    Orthop Nurs; 1985; 4(4):53-4. PubMed ID: 2981040
    [No Abstract]   [Full Text] [Related]  

  • 2. [Side effects of cervical myelography/radiculography with metrizamide (Amipaque)].
    Lesak F
    Ugeskr Laeger; 1986 Nov; 148(47):3134-6. PubMed ID: 3810908
    [No Abstract]   [Full Text] [Related]  

  • 3. [Side effects of metrizamide (Amipaque) cervical myelography (author's transl)].
    Okada K; Nishimatsu T; Wada H; Komatsu T
    No Shinkei Geka; 1982 May; 10(5):511-8. PubMed ID: 7110515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequelae of metrizamide myelography in 200 examinations.
    Baker RA; Hillman BJ; McLennan JE; Strand RD; Kaufman SM
    AJR Am J Roentgenol; 1978 Mar; 130(3):499-502. PubMed ID: 415557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amipaque myelography. The side effects compared with Dimer X.
    Ahlgren P
    Neuroradiology; 1975 Aug; 9(4):197-202. PubMed ID: 1186965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast agents for myelography: clinical and radiological evaluation of Amipaque and Pantopaque.
    Kieffer SA; Binet EF; Esquerra JV; Hantman RP; Gross CE
    Radiology; 1978 Dec; 129(3):695-705. PubMed ID: 103130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lumbar myelography today. Experience with metrizamide, a water-soluble, non-ionic contrast medium.
    Sage MR; Benness GT; Perrett LV; Mansfield J
    Med J Aust; 1981 Feb; 1(4):175-6. PubMed ID: 7015091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelography with metrizamide--an analysis of the complications encountered in cervical, thoracic and lumbar myelography.
    McCormick CC; ApSimon HT; Chakera TM
    Aust N Z J Med; 1981 Dec; 11(6):645-50. PubMed ID: 6949540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of metrizamide for neuroradiology in chilren.
    Swick HM; Sty JR; Haughton VM
    Ann Neurol; 1978 May; 3(5):409-15. PubMed ID: 310277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using metrizamide for lumbar myelography: adverse reactions and nursing implications.
    Byers VL; Gendell H
    J Neurosurg Nurs; 1982 Dec; 14(6):315-7. PubMed ID: 6924690
    [No Abstract]   [Full Text] [Related]  

  • 11. Metrizamide as contrast medium for myelography and ventriculography. Preliminary clinical experiences.
    Gonsette RE
    Acta Radiol Suppl; 1973; 335():346-58. PubMed ID: 4549779
    [No Abstract]   [Full Text] [Related]  

  • 12. Lumbar myelography with iohexol and metrizamide. A comparative multicenter prospective study.
    Kieffer SA; Binet EF; Davis DO; Gabrielsen TO; Kido DK; Latchaw RE; Turski PA; Shaw DD
    Invest Radiol; 1985; 20(1 Suppl):S22-30. PubMed ID: 3882614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EEG changes 24 hours after myelography with metrizamide.
    Koshino Y; Isaki K; Kihara Y; Yamaguchi N; Yugami H; Yamamoto S; Baba H; Umeda S; Shima I; Nomura S
    Folia Psychiatr Neurol Jpn; 1985; 39(1):59-70. PubMed ID: 4054762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metrizamide myelography for cervical spinal cord injuries.
    Leo JS; Bergeron RT; Kricheff II; Benjamin MV
    Radiology; 1978 Dec; 129(3):707-11. PubMed ID: 725046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumbar myelography with iohexol and metrizamide: a comparative multicenter prospective study.
    Kieffer SA; Binet EF; Davis DO; Gabrielsen TO; Kido DK; Latchaw RE; Turski PA; Shaw DD
    Radiology; 1984 Jun; 151(3):665-70. PubMed ID: 6371890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lumbar myelography with metrizamide-a new non-ionic contrast medium.
    Grainger RG
    Br J Radiol; 1976 Dec; 49(588):996-1003. PubMed ID: 793673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible neurologic complications of metrizamide myelography.
    Meador K; Hamilton WJ; El Gammal TA; Demetropoulos KC; Nichols FT
    Neurology; 1984 Jun; 34(6):817-21. PubMed ID: 6539448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of lumbar myelography with amipaque and dimer-X.
    Irstam L; Selldén U
    Acta Radiol Diagn (Stockh); 1976 Mar; 17(2):145-59. PubMed ID: 1274652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metrizamide--CSF contrast medium. Analysis of clinical application in 215 patients.
    Sackett JF; Strother CM; Quaglieri CE; Javid MJ; Levin AB; Duff TA
    Radiology; 1977 Jun; 123(3):779-82. PubMed ID: 860047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of levomepromazine on EEG and on clinical side effects after lumbar myelography with metrizamide.
    Standnes B; Oftedal SI; Weber H
    Acta Radiol Diagn (Stockh); 1982; 23(2):111-4. PubMed ID: 7090846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.